Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA announces a new insulin recall | VR training for endovascular surgery | Infective endocarditis after TAVR
Friday, April 15, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces new insulin recall due to potential labeling issue

The recall is focused on a single batch distributed from December 2021 to March 2022.

READ MORE >
insulin_glargine_1.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA announces new insulin recall due to potential labeling issue

Share on Twitter Share on Facebook Share on Linkedin
insulin_glargine_1.jpg
The recall is focused on a single batch distributed from December 2021 to March 2022.
READ MORE >

Virtual reality specialists launch new training solutions for endovascular surgery

The virtual reality training sessions were designed to feature "the same sights, sound and sensations a surgeon would encounter during real procedures." 

READ MORE >
virtual reality endovascular surgery in the cath lab. The virtual reality training sessions were designed to feature "the same sights, sound and sensations a surgeon would encounter during real procedures ." 
Share on Twitter Share on Facebook Share on Linkedin

Virtual reality specialists launch new training solutions for endovascular surgery

Share on Twitter Share on Facebook Share on Linkedin
virtual reality endovascular surgery in the cath lab. The virtual reality training sessions were designed to feature "the same sights, sound and sensations a surgeon would encounter during real procedures ." 
The virtual reality training sessions were designed to feature "the same sights, sound and sensations a surgeon would encounter during real procedures." 
READ MORE >

The latest data on mitral valve infective endocarditis after TAVR

Self-expanding heart valves and the presence of significant PVL were both linked to a heightened risk of mitral valve infective endocarditis after TAVR. 

READ MORE >
A view showing the close relationship between the mitral and aortic valves and how the overhang of a longer TAVR valve in the left ventricular outflow tract (LVOT) may cause friction near the mitral valve. Image from a mitral echo assessment using Siemens eSie Valves software at ACC22.
Share on Twitter Share on Facebook Share on Linkedin

The latest data on mitral valve infective endocarditis after TAVR

Share on Twitter Share on Facebook Share on Linkedin
A view showing the close relationship between the mitral and aortic valves and how the overhang of a longer TAVR valve in the left ventricular outflow tract (LVOT) may cause friction near the mitral valve. Image from a mitral echo assessment using Siemens eSie Valves software at ACC22.
Self-expanding heart valves and the presence of significant PVL were both linked to a heightened risk of mitral valve infective endocarditis after TAVR. 
READ MORE >

Featured Articles

Links to the ACC.22 late-breaking clinical trials

Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 

READ MORE >
The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC
Share on Twitter Share on Facebook Share on Linkedin

Links to the ACC.22 late-breaking clinical trials

Share on Twitter Share on Facebook Share on Linkedin
The American College of Cardiology (ACC) annual meeting ACC.22 is the premier source for the latest cardiac science. #ACC22 Here are links to all the late breaking studies, trials and late-breaker science at the annual meeting conference. #ACC2022 #ACC
Learn more about the late-breaking studies presented at ACC.22 in Washington, D.C. 
READ MORE >

Missing New York cardiologist found dead

“If you were a patient of Dr. Verga’s, your heart was in brilliant hands,” according to one loving tribute. The 45-year-old cardiologist had been missing since March 20. 

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

Missing New York cardiologist found dead

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
“If you were a patient of Dr. Verga’s, your heart was in brilliant hands,” according to one loving tribute. The 45-year-old cardiologist had been missing since March 20. 
READ MORE >

Drug-coated balloons comparable to drug-eluting stents when PCI patients have a high bleeding risk

Drug-coated balloons were associated with a lower risk of bleeding after PCI than drug-eluting stents, the study's authors reported. 

READ MORE >
 Drug-coated balloons were associated with a lower risk of bleeding after PCI than drug-eluting stents, the study's authors reported. 
Share on Twitter Share on Facebook Share on Linkedin

Drug-coated balloons comparable to drug-eluting stents when PCI patients have a high bleeding risk

Share on Twitter Share on Facebook Share on Linkedin
 Drug-coated balloons were associated with a lower risk of bleeding after PCI than drug-eluting stents, the study's authors reported. 
Drug-coated balloons were associated with a lower risk of bleeding after PCI than drug-eluting stents, the study's authors reported. 
READ MORE >

An updated look at what cardiologists know about heart damage among COVID-19 patients

An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19. 

READ MORE >
Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.
Share on Twitter Share on Facebook Share on Linkedin

An updated look at what cardiologists know about heart damage among COVID-19 patients

Share on Twitter Share on Facebook Share on Linkedin
Nurses caring for a COVID-19 patient in the COVID unit at Banner University Medical Center in Phoenix.
An international analysis published in Circulation and a new scientific statement from the American Heart Association both explore the latest data on heart complications associated with COVID-19. 
READ MORE >

VIDEO: TAVR durability outperforms surgical valves

Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.

READ MORE >
In a late-breaking long-term analysis presented at ACC 2022, the Medtronic CoreValve TAVR valve outperformed the surgical aortic valve replacement (SAVR) in terms of durability.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: TAVR durability outperforms surgical valves

Share on Twitter Share on Facebook Share on Linkedin
In a late-breaking long-term analysis presented at ACC 2022, the Medtronic CoreValve TAVR valve outperformed the surgical aortic valve replacement (SAVR) in terms of durability.
Michael J. Reardon, MD, professor of cardiothoracic surgery and Allison Family Distinguished chair of cardiovascular research at Houston Methodist DeBakey Heart and Vascular Center, presented pooled data at ACC.22 from the CoreValve SURTAVI trials that found transcatheter aortic valve replacement (TAVR) was more durable than surgical aortic valve replacement (SAVR) devices.
READ MORE >

In Other News

Survey results reveal what influences medical students to choose radiology as a specialty

Understanding these findings, experts suggested, is an important aspect of addressing the worldwide shortage of radiologists.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Survey results reveal what influences medical students to choose radiology as a specialty

Share on Twitter Share on Facebook Share on Linkedin
Understanding these findings, experts suggested, is an important aspect of addressing the worldwide shortage of radiologists.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme